Patents/Assignees

Geovax, Inc.

9 patents in portfolio

US12577589utility2026
Vaccines and Uses Thereof to Induce an Immune Response to Sars-cov2
0 cites
US12370249utility2025
Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Marburg Virus Glycoprotein (GP) and Matrix Protein (VP40)
0 cites
US12329808utility2025
Compositions and Methods for Generating an Immune Response to Treat or Prevent Malaria
0 cites
US12247214utility2025
Vaccinia Viral Vectors Encoding Chimeric Virus Like Particles
0 cites
US11896657utility2024
Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Marburg Virus Glycoprotein (GP) and Matrix Protein (VP40)
0 cites
US11897919utility2024
Multivalent HIV Vaccine Boost Compositions and Methods of Use
0 cites
US11857611utility2024
Compositions and Methods for Generating an Immune Response to Treat or Prevent Malaria
0 cites
US11701418utility2023
Replication-deficient Modified Vaccinia Ankara (MVA) Expressing Ebola Virus Glycoprotein (GP) and Matrix Protein (VP40)
0 cites
US11638750utility2023
Methods for Generating a Zikv Immune Response Utilizing a Recombinant Modified Vaccina Ankara Vector Encoding the NS1 Protein
0 cites